The contribution of clinical pharmacology surrogates and models to drug development - a critical appraisal

被引：62

作者：

Rolan, P ^{[1
]}

机构：

[1] UNIV MANCHESTER, NEURAXIS LTD, MANCHESTER M15 6SH, LANCS, ENGLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1997年 / 44卷 / 03期

关键词：

surrogates; models; validation; drug development;

D O I：

10.1046/j.1365-2125.1997.t01-1-00583.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：219 / 225

页数：7

共 38 条

[1]

[Anonymous], 1989, NEW ENGL J MED, V321, P406

[2] Tucaresol increases oxygen affinity and reduces haemolysis in subjects with sickle cell anaemia [J].

Arya, R ;

Rolan, PE ;

Wootton, R ;

Posner, J ;

Bellingham, AJ .

BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (04) :817-821

[3] MEASUREMENT OF HUMAN CEREBRAL MONOAMINE-OXIDASE TYPE-B (MAO-B) ACTIVITY WITH POSITRON EMISSION TOMOGRAPHY (PET) - A DOSE RANGING STUDY WITH THE REVERSIBLE INHIBITOR RO-19-6327 [J].

BENCH, CJ ;

PRICE, GW ;

LAMMERTSMA, AA ;

CREMER, JC ;

LUTHRA, SK ;

TURTON, D ;

DOLAN, RJ ;

KETTLER, R ;

DINGEMANSE, J ;

DAPRADA, M ;

BIZIERE, K ;

MCCLELLAND, GR ;

JAMIESON, VL ;

WOOD, ND ;

FRACKOWIAK, RSJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (02) :169-173

[4] SURROGATE END-POINTS - A BASIS FOR A RATIONAL APPROACH [J].

BOISSEL, JP ;

COLLET, JP ;

MOLEUR, P ;

HAUGH, M .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (03) :235-244

[5]

CANTOR SB, 1995, PRIMARY CARE, V22, P261

[6]

CUTLER N, 1995, NEUROLOGY, V45, pS5

[7] LABORATORY METHODS FOR THE CONDUCT OF EXPERIMENTAL MALARIA CHALLENGE OF VOLUNTEERS [J].

DAVIS, JR .

VACCINE, 1994, 12 (04) :321-327

[8]

Deakin JFW, 1994, STRATEGIES STUDYING, V1, P211

[9]

EMERY P, 1993, BRIT J RHEUMATOL, V32, P3

[10] CALCIUM-ANTAGONISTS AND MORTALITY - ANOTHER CASE OF THE NEED FOR CLINICAL JUDGMENT [J].

FAGAN, TC .

ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (20) :2145-2145

← 1 2 3 4 →